Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Engelmann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Hepatology (Baltimore, Md.)|May 23, 2015
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formationAnggakusuma, Inés Romero-Brey, Carola Berger, et al.
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Viruses|July 27, 2022
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus InoculationMarcha Badenhorst, Armin Saalmüller, Janet M Daly, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Hepatology (Baltimore, Md.)|May 23, 2015
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formationAnggakusuma, Inés Romero-Brey, Carola Berger, et al.
Hepatology Communications|February 7, 2018
Hepatitis E virus replication and interferon responses in human placental cellsLeonard Knegendorf, Svenja A Drave, Viet Loan Dao Thi, et al.
Journal of Hepatology|April 16, 2020
C19orf66 is an interferon-induced inhibitor of HCV replication that restricts formation of the viral replication organelleVolker Kinast, Agnieszka Plociennikowska, Anggakusuma, et al.
The Journal of Infectious Diseases|April 29, 2017
Virucidal Activity of World Health Organization-Recommended Formulations Against Enveloped Viruses, Including Zika, Ebola, and Emerging CoronavirusesAnindya Siddharta, Stephanie Pfaender, Nathalie Jane Vielle, et al.
Journal of Virology|March 4, 2021
Initial HCV infection of adult hepatocytes triggers a temporally structured transcriptional program containing diverse pro- and anti-viral elementsBirthe Tegtmeyer, Gabrielle Vieyres, Daniel Todt, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2020
Robust hepatitis E virus infection and transcriptional response in human hepatocytesDaniel Todt, Martina Friesland, Nora Moeller, et al.
Viruses|July 27, 2022
An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus InoculationMarcha Badenhorst, Armin Saalmüller, Janet M Daly, et al.
Science Advances|November 5, 2020
Liver-expressed <i>Cd302</i> and <i>Cr1l</i> limit hepatitis C virus cross-species transmission to miceRichard J P Brown, Birthe Tegtmeyer, Julie Sheldon, et al.
Pageof 2